According to the Low Dose Naltrexone home page [LDN],
Hereditary Spastic Paraparesis is a neurodegenerative disease that is associated with
autoimmune processes.
[LDN] reports that all patients with Hereditary Spastic Paraparesis whom the late
Dr. Bihari [Bihari2003] treated using LDN
"have experienced a halt in progression of their illness.
In many patients there was a marked remission in signs and symptoms of the disease."
Dr. Weyrich has been trained to use Low Dose Naltrexone (LDN).
However, Dr. Weyrich has not treated any cases of Hereditary Spastic Paraparesis
with LDN.
Please see What is Low Dose Naltrexone?
for more information.